Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuala Moran

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Nature Biotechnology|December 14, 2011
European court bans embryonic stem cell patentsNuala Moran
Nature Biotechnology|January 11, 2012
Incyte comes of age with JAK inhibitor approvalNuala Moran
Nature Biotechnology|January 10, 2008
Fractured European market undermines biosimilar launchesNuala Moran
Nature Biotechnology|July 12, 2012
Swiss hope for phoenix from Merck Serono's ashesNuala Moran
Nature Biotechnology|January 12, 2011
Boehringer splashes out on bispecific antibody platformsNuala Moran
Nature Biotechnology|May 9, 2012
Affymax poised to challenge AmgenNuala Moran
Nature Biotechnology|August 9, 2008
GSK slashes internal R&DNuala Moran
Nature Biotechnology|March 9, 2007
Public sector seeks to bridge 'valley of death'Nuala Moran
Nature Biotechnology|July 11, 2007
Technology commercialization firms float in UK - but not elsewhereNuala Moran
Nature Biotechnology|September 12, 2013
Biotechs to tap into Horizon 2020's $93 billionNuala Moran
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Nature Biotechnology|December 14, 2011
European court bans embryonic stem cell patentsNuala Moran
Nature Biotechnology|January 11, 2012
Incyte comes of age with JAK inhibitor approvalNuala Moran
Nature Biotechnology|January 10, 2008
Fractured European market undermines biosimilar launchesNuala Moran
Nature Biotechnology|July 12, 2012
Swiss hope for phoenix from Merck Serono's ashesNuala Moran
Nature Biotechnology|January 12, 2011
Boehringer splashes out on bispecific antibody platformsNuala Moran
Nature Biotechnology|May 9, 2012
Affymax poised to challenge AmgenNuala Moran
Nature Biotechnology|August 9, 2008
GSK slashes internal R&DNuala Moran
Nature Biotechnology|March 9, 2007
Public sector seeks to bridge 'valley of death'Nuala Moran
Nature Biotechnology|July 11, 2007
Technology commercialization firms float in UK - but not elsewhereNuala Moran
Nature Biotechnology|September 12, 2013
Biotechs to tap into Horizon 2020's $93 billionNuala Moran
Pageof 5